ENGOT-OV72/ROSELLA
Trial Description:
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Investigator’s Choice in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Recruiting
Contact person:
dlorusso